Sponsor Pipeline

Zura Bio Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-21 NCT06843239
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)		 overall status: Recruiting → Active, Not Recruiting
2026-07-21 NCT06843239
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)		 Trial sites expanded: 51 -> 60 locations
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06993610 Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense Hidradenitis Suppurativa (HS) Active, Not Recruiting
NCT06843239 Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) Systemic Sclerosis (SSc) Active, Not Recruiting
Disease Areas
Scleroderma (1) Hidradenitis Suppurativa (1)
Get alerts when Zura Bio Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free